Novartis Japan Apologizes Again for Second Side-Effects Scandal

The Japanese unit of Novartis has apologized for failing to report the side-effects of its leukemia drugs, Gleevec and Tasigna -- the second recent scandal the drugmaker has faced surrounding inappropriately-reported side-effects.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news